Pulmonary pressures and death in heart failure: a community study
- PMID: 22240126
- PMCID: PMC3258551
- DOI: 10.1016/j.jacc.2011.06.076
Pulmonary pressures and death in heart failure: a community study
Abstract
Objectives: The purpose of this study was to determine among community patients with heart failure (HF) whether pulmonary artery systolic pressure (PASP) assessed by Doppler echocardiography was associated with death and improved risk prediction over established factors, using the integrated discrimination improvement and net reclassification improvement.
Background: Although several studies have focused on idiopathic pulmonary arterial hypertension, less is known about pulmonary hypertension among patients with HF, particularly about its prognostic value in the community.
Methods: Between 2003 and 2010, Olmsted County residents with HF prospectively underwent assessment of ejection fraction, diastolic function, and PASP by Doppler echocardiography.
Results: PASP was recorded in 1,049 of 1,153 patients (mean age 76 ± 13; 51% women). Median PASP was 48 mm Hg (25th to 75th percentile: 37.0 to 58.0). There were 489 deaths after a follow-up of 2.7 ± 1.9 years. There was a strong positive graded association between PASP and mortality. Increasing PASP was associated with an increased risk of death (hazard ratio [HR]: 1.45, 95% confidence interval [CI]: 1.13 to 1.85 for tertile 2; HR: 2.07, 95% CI: 1.62 to 2.64 for tertile 3 vs. tertile 1), independently of age, sex, comorbidities, ejection fraction, and diastolic function. Adding PASP to models including these clinical characteristics resulted in an increase in the c-statistic from 0.704 to 0.742 (p = 0.007), an integrated discrimination improvement gain of 4.2% (p < 0.001), and a net reclassification improvement of 14.1% (p = 0.002), indicating that PASP improved prediction of death over traditional prognostic factors. All results were similar for cardiovascular death.
Conclusions: Among community patients with HF, PASP strongly predicts death and provides incremental and clinically relevant prognostic information independently of known predictors of outcomes.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Figures




Comment in
-
Pulmonary hypertension: the great leveler.J Am Coll Cardiol. 2012 Jan 17;59(3):232-4. doi: 10.1016/j.jacc.2011.09.052. J Am Coll Cardiol. 2012. PMID: 22240127 No abstract available.
-
Echocardiographic evaluation of pulmonary artery pressure in patients with heart failure.J Am Coll Cardiol. 2012 Jul 3;60(1):83; author reply 83-4. doi: 10.1016/j.jacc.2012.02.050. J Am Coll Cardiol. 2012. PMID: 22742409 No abstract available.
References
-
- Abramson SV, Burke JF, Kelly JJ, Jr., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 1992;116:888–95. - PubMed
-
- Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 2001;37:183–8. - PubMed
-
- Guglin M, Khan H. Pulmonary hypertension in heart failure. J Card Fail. 2010;16:461–74. - PubMed
-
- Hoeper MM, Barbera JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54:S85–96. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous